A detailed history of Dunhill Financial, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Dunhill Financial, LLC holds 5 shares of CRL stock, worth $1,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 4 25.0%
Holding current value
$1,031
Previous $1.16 Million 4.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$206.39 - $268.73 $206 - $268
1 Added 25.0%
5 $1.11 Million
Q4 2023

Feb 12, 2024

BUY
$164.52 - $238.84 $658 - $955
4 New
4 $856,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.5B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.